Sunil Healthcare Ltd
Incorporated in 1976, Sunil Healthcare Ltd is a manufacturer of Empty Hard Gelatin, HPMC Capsule Shells & Ayurvedic Medicines[1]
- Market Cap ₹ 76.9 Cr.
- Current Price ₹ 75.0
- High / Low ₹ 104 / 50.6
- Stock P/E
- Book Value ₹ 65.8
- Dividend Yield 0.00 %
- ROCE 2.98 %
- ROE -2.61 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.14 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 2.20% over past five years.
- Company has a low return on equity of 7.02% over last 3 years.
- Earnings include an other income of Rs.4.13 Cr.
- Company has high debtors of 164 days.
- Working capital days have increased from 108 days to 192 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|
108.48 | 91.33 | 80.88 | 70.02 | 90.62 | 119.16 | 110.49 | 90.19 | 85.74 | |
93.33 | 77.44 | 69.62 | 76.95 | 85.27 | 101.78 | 94.32 | 85.93 | 79.17 | |
Operating Profit | 15.15 | 13.89 | 11.26 | -6.93 | 5.35 | 17.38 | 16.17 | 4.26 | 6.57 |
OPM % | 13.97% | 15.21% | 13.92% | -9.90% | 5.90% | 14.59% | 14.63% | 4.72% | 7.66% |
1.25 | 2.23 | 0.18 | 14.41 | 5.52 | 1.68 | 4.50 | 5.05 | 4.13 | |
Interest | 4.18 | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.78 | 6.21 |
Depreciation | 4.33 | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.09 | 5.87 |
Profit before tax | 7.89 | 6.31 | -0.88 | -5.60 | -0.55 | 9.26 | 9.49 | -2.56 | -1.38 |
Tax % | 36.25% | 28.68% | -20.45% | -11.25% | 16.36% | 30.67% | 29.50% | -30.08% | |
5.03 | 4.49 | -0.69 | -4.96 | -0.64 | 6.42 | 6.68 | -1.79 | -1.29 | |
EPS in Rs | 4.91 | 4.38 | -0.67 | -4.84 | -0.62 | 6.26 | 6.51 | -1.75 | -1.26 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 0% |
TTM: | -7% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 6% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | 36% |
3 Years: | 26% |
1 Year: | 48% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 7% |
Last Year: | -3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
Reserves | 32.65 | 37.18 | 36.52 | 34.34 | 33.46 | 39.70 | 45.74 | 57.96 | 57.25 |
44.53 | 60.62 | 55.08 | 49.45 | 49.82 | 34.68 | 36.79 | 66.16 | 61.63 | |
31.41 | 34.16 | 35.88 | 36.19 | 27.03 | 25.06 | 28.01 | 24.13 | 29.73 | |
Total Liabilities | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.50 | 158.86 |
59.72 | 70.92 | 68.83 | 69.97 | 69.80 | 69.97 | 70.43 | 87.16 | 95.49 | |
CWIP | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 5.66 | 0.02 |
Investments | 0.00 | 0.10 | 0.11 | 0.11 | 1.07 | 1.03 | 0.00 | 0.00 | 0.00 |
59.00 | 71.00 | 66.32 | 60.14 | 49.68 | 36.94 | 50.35 | 65.68 | 63.35 | |
Total Assets | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.50 | 158.86 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
10.79 | 5.48 | 14.73 | 4.31 | 16.99 | 22.51 | 7.47 | -15.40 | |
-12.85 | -17.18 | -2.80 | -2.52 | -11.36 | -4.24 | -3.40 | -10.11 | |
2.23 | 11.02 | -11.63 | -1.56 | -6.42 | -18.56 | -3.75 | 25.00 | |
Net Cash Flow | 0.17 | -0.67 | 0.30 | 0.23 | -0.79 | -0.29 | 0.32 | -0.51 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 129.57 | 192.39 | 177.08 | 122.81 | 94.37 | 57.86 | 93.85 | 164.27 |
Inventory Days | 76.09 | 101.63 | 213.19 | 322.80 | 117.09 | 83.25 | 105.15 | 110.57 |
Days Payable | 138.91 | 180.29 | 294.23 | 292.81 | 109.16 | 65.01 | 114.04 | 47.85 |
Cash Conversion Cycle | 66.75 | 113.73 | 96.04 | 152.81 | 102.30 | 76.09 | 84.96 | 226.99 |
Working Capital Days | 81.09 | 137.76 | 125.82 | 105.51 | 84.06 | 46.50 | 84.80 | 192.11 |
ROCE % | 11.60% | 5.43% | 1.65% | 5.12% | 14.25% | 15.30% | 2.98% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2h
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Newspaper clipping regarding publication of unaudited financial results for the 2nd quarter/ 1st half year ended 30.09.2024 of the FY 2024-25
-
Board Meeting Outcome for Outcome Of The 261St Board Meeting Held On 13.11.2024
13 Nov - Approved un-audited financial results for Q2 FY 2024-25.
- Un-Audited Financial Results (Standalone And Consolidated) For The 2Nd Quarter/ 1St Half Year Of The FY 2024-25 Ended On September 30, 2024 13 Nov
-
Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 13.11.2024 Through Video Conferencing/Audio Visual Connection, Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (LODR) Regulations, 2015.
31 Oct - Board meeting scheduled for November 13, 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Nov 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Aug 2016TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
Business Overview:[1]
Company is the second-largest manufacturer of Empty Hard Shell Gelatin Capsules in India which its sells under the brand name Sunloc. Company does production of double lock, triple lock, multiple groove capsules of EHGC & some proportion of vegan HPMC (Hydroxy Propyl Methyl Cellulose) along with liner, circular, two color printing & 360degree printing being offered